Skip to main content

Advertisement

Log in

Genomewide association study identifies no major founder variant in Caucasian moyamoya disease

  • Research Note
  • Published:
Journal of Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  • Fukuda M. and Kuroda T. S. 2002 Slac2-c (synaptotagmin-like protein homologue lacking C2 domains-c), a novel linker protein that interacts with Rab27, myosin Va/VIIa, and actin. J. Biol. Chem. 277, 43096–43103.

    Article  CAS  PubMed  Google Scholar 

  • Goto Y. and Yonekawa Y. 1992 Worldwide distribution of moyamoya disease. Neurol. Med. Chir. (Tokyo) 32, 883–886.

    Article  CAS  Google Scholar 

  • Guo D. C., Papke C. L., Tran-Fadulu V., Regalado E. S., Avidan N., Johnson R. J. et al. 2009 Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am. J. Hum. Genet. 84, 617–627.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kuroda S. and Houkin K. 2008 Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 7, 1056–1066.

    Article  PubMed  Google Scholar 

  • Liu W., Hashikata H., Inoue K., Matsuura N., Mineharu Y., Kobayashi H. et al. 2010 A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ. Health Prev. Med. 15, 94–104.

    Article  PubMed Central  PubMed  Google Scholar 

  • Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T. et al. 2011 Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 6, e22542.

    Article  Google Scholar 

  • Liu W., Harada K. H., Hitomi T., Kobayashi H. and Koizumi A. 2012 Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol. Med. Chir. (Tokyo) 52, 299–303.

    Google Scholar 

  • Miyatake S., Miyake N., Touho H., Nishimura-Tadaki A., Kondo Y., Okada I. et al. 2012 Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78, 803–810.

    Article  CAS  PubMed  Google Scholar 

  • Roder C., Peters V., Kasuya H., Nishizawa T., Wakita S., Berg D. et al. 2011 Analysis of ACTA2 in European Moyamoya disease patients. Eur. J. Paediatr. Neurol. 15, 117–122.

    Article  PubMed  Google Scholar 

  • Shimojima K. and Yamamoto T. 2009 ACTA2 is not a major disease-causing gene for moyamoya disease. J. Hum. Genet. 54, 687–688.

    Article  PubMed  Google Scholar 

  • Suzuki J. and Takaku A. 1969 Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch. Neurol. 20, 288–299.

    Article  CAS  PubMed  Google Scholar 

  • Takeuchi K. and Shimizu K. 1957 Hypogenesis of bilateral internal carotid arteries. Brain Nerve 9, 37–43.

    Google Scholar 

  • Wu Z., Jiang H., Zhang L., Xu X., Zhang X., Kang Z. et al. 2012 Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS One 7, e48179.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported mainly by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Kiban Kenkyu A: 22249020) and the Ministry of Health, Labour and Welfare of Japan (H23-Nanji-Ippan-019, chaired by Dr Nobuo Hashimoto) and partially by a grant from Creative Scientific Research (19G50314). We thank all individuals for their participation in this study. We also thank Dr David Školoudík (Department of Neurology, University Hospital, Ostrava, Czech Republic); Dr Martin Kucharík (Department of Neurology, 1st Faculty of Medicine, Charles University and General Teaching Hospital, Prague, Czech Republic); Dr Aleš Tomek (Department of Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic); Dr Martin Kovář (Department of Neurology, Na Homolce Hospital, Prague, Czech Republic); Dr Jan Fiksa (Department of Neurology, Military University Hospital, Prague, Czech Republic); Dr Michael J. Schmeisser (Institute for Anatomy and Cell Biology, Ulm University, Ulm, Germany); Dr Vera Alexandra Neves dos Santos (Department of Pediatry, Hospital de Faro, Faro, Portugal); Dr Vera Peters (Department of Neurosurgery, University of Tübingen, Tübingen, Germany); Prof. Daniela Berg and Ms Claudia Schulte (both Department of Neurology, University of Tübingen, Tübingen, Germany) and Prof. Martin Schöning (Department of Pediatrics, University of Tübingen, Tübingen, Germany) for their patients recruitment.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to BORIS KRISCHEK or AKIO KOIZUMI.

Additional information

[Liu W., Senevirathna S. T. M. L. D., Hitomi T., Kobayashi H., Roder C., Herzig R., Kraemer M., Voormolen M. H. J., Cahová P., Krischek B. and Koizumi A. 2013 Genomewide association study identifies no major founder variant in Caucasian moyamoya disease. J. Genet. 92, xx–xx]

Wanyang Liu and S. T. M. L. D. Senevirathna contributed equally to this work.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

(PDF 694 KB)

Rights and permissions

Reprints and permissions

About this article

Cite this article

LIU, W., SENEVIRATHNA, S.T.M.L.D., Hitomi, T. et al. Genomewide association study identifies no major founder variant in Caucasian moyamoya disease. J Genet 92, 605–609 (2013). https://doi.org/10.1007/s12041-013-0304-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-013-0304-5

Keywords

Navigation